WallStreetZenWallStreetZen

NASDAQ: MEIP
Mei Pharma Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

MEIP past revenue growth

How has MEIP's revenue growth performed historically?
Company
16.1%
Industry
148.4%
Market
16.96%
MEIP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
MEIP's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
MEIP's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

MEIP earnings and revenue history

Current Revenue
$72.6M
Current Earnings
$19.8M
Current Profit Margin
27.3%

MEIP Return on Equity

Current Company
39.7%
Current Industry
-63.5%
Current Market
188%
MEIP's Return on Equity (39.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when MEIP announces earnings.

MEIP Return on Assets

Current Company
18.3%
Current Industry
2.9%
MEIP is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

MEIP Return on Capital Employed

Current Company
28.15%
Current Industry
19.5%
MEIP has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

MEIP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
MEIP$72.65M$21.69M$19.84M+83.24%N/A
SYBX$3.37M-$51.97M-$57.28M+5.99%N/A
AIM$202.00k-$28.44M-$28.96M-11.26%N/A
CERO$0.00-$2.44M-$2.54MN/AN/A
LUMO$2.05M-$34.02M-$34.03M-30.31%N/A
View Top Biotech Stocks

MEIP earnings dates

Next earnings date
May 9, 2024

Mei Pharma Earnings & Revenue FAQ

What were MEIP's earnings last quarter?

On Invalid Date, Mei Pharma (NASDAQ: MEIP) reported Q4 2023 earnings per share (EPS) of -$1.66, up 207.79% year over year. Total Mei Pharma earnings for the quarter were -$11.06 million. In the same quarter last year, Mei Pharma's earnings per share (EPS) was $1.54.

If you're new to stock investing, here's how to buy Mei Pharma stock.

What was MEIP's earnings growth in the past year?

As of Q2 2024, Mei Pharma's earnings has grown year over year. Mei Pharma's earnings in the past year totalled $19.84 million.

What is MEIP's earnings date?

Mei Pharma's earnings date is Invalid Date. Add MEIP to your watchlist to be reminded of MEIP's next earnings announcement.

What was MEIP's revenue last quarter?

On Invalid Date, Mei Pharma (NASDAQ: MEIP) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Mei Pharma's revenue was $32.74 million.

What was MEIP's revenue growth in the past year?

As of Q2 2024, Mei Pharma's revenue has grown 16.1% year over year. This is 132.3 percentage points lower than the US Biotechnology industry revenue growth rate of 148.4%. Mei Pharma's revenue in the past year totalled $72.65 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.